Acuta Capital Partners’s Alimera Sciences ALIM Stock Holding History

Acuta Capital Partners’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17,833	Closed	-$262K	–	31
2018 Q3	$262K	Sell	17,833 -47,122	-73%	-$717K	0.09%	29
2018 Q2	$953K	Hold	64,955	–	–	0.17%	49
2018 Q1	$1M	Hold	64,955	–	–	0.16%	46
2017 Q4	$1.3M	Hold	64,955	–	–	0.24%	50
2017 Q3	$1.31M	Hold	64,955	–	–	0.24%	48
2017 Q2	$1.35M	Hold	64,955	–	–	0.38%	40
2017 Q1	$1.36M	Hold	64,955	–	–	0.32%	46
2016 Q4	$1.05M	Hold	64,955	–	–	0.39%	34
2016 Q3	$1.45M	Hold	64,955	–	–	0.55%	40
2016 Q2	$1.2M	Hold	64,955	–	–	0.58%	44
2016 Q1	$1.71M	Hold	64,955	–	–	0.95%	26
2015 Q4	$2.36M	Hold	64,955	–	–	1.13%	26
2015 Q3	$2.15M	Hold	64,955	–	–	1.25%	31
2015 Q2	$4.49M	Sell	64,955 -5,366	-8%	-$370K	2.78%	10
2015 Q1	$5.29M	Sell	70,321 -133	-0.2%	-$10.5K	4.45%	4
2014 Q4	$5.86M	Buy	+70,454	New	+$5.72M	3.96%	4

Other funds holding ALIM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Acuta Capital Partners's ALIM Position: Q4 2018 in Review

Acuta Capital Partners sold out of Alimera Sciences (ALIM) in Q4 2018, closing a stake of 17,833 shares — an estimated $262K sold.

Acuta Capital Partners first reported a position in ALIM in Q4 2014 and held it in 16 quarters. The position peaked at $5.86M in Q4 2014. 39 funds tracked by Wall St. Rank hold ALIM as of Q4 2018.

Acuta Capital Partners reported no remaining Alimera Sciences position as of Q4 2018 after selling out during the quarter.
Acuta Capital Partners sold 17,833 Alimera Sciences shares in Q4 2018, an estimated $262K.
Acuta Capital Partners first reported a position in Alimera Sciences in Q4 2014 and held it in 16 quarters.
Acuta Capital Partners's Alimera Sciences position peaked at $5.86M in Q4 2014.
39 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2018.

Based on Acuta Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.